NSW Minister for Health announces two prestigious scholarships for medical device researchers.
The Hon Jillian Skinner, NSW Minister for Health, last night awarded prestigious QB3 Rosenman Scholarships to Dr Sheridan Gho and Dr Michael Weaver, both from the University of Wollongong. The announcement occurred during a Medical Device Showcase at world leading incubator, ATP Innovations. The event highlighted some of the incredible medical device research being conducted in NSW and showcased the commercial pathway each researcher has commenced.
Dr Gho and Dr Weaver have been working to address lymphoedema – a condition of localised fluid retention and painful tissue swelling, caused by a compromised lymphatic system. Lymphoedema is a disease that effects one in three breast cancer survivors. Approximately 15,000 women will be diagnosed with breast cancer in Australia during 2014. Dr Gho and Dr Weaver’s invention involves a wearable sleeve that treats and manages the painful condition by actively massaging the lymphatic system, allowing patients to conduct normal lives.
Minister Skinner said that Dr Gho and Dr Weaver had “demonstrated entrepreneurial literacy, persistence and a commitment to understanding how to close the gap between the development of a device and how to bring it to market,” following their completion of an intensive three-month Medical Device Commercialisation Training Program run by ATP Innovations.
“The NSW Government and the Office for Health and Medical Research are proud to fund these two scholarships, knowing the knowledge Sheridan and Michael gain now will be shared with many others on their return,” said Minister Skinner.
Mr Ben Wright, Medical Device Commercialisation Training Program Director said that “NSW Health and the Office for Health and Medical Research have been visionary in their establishment of both the NSW Medical Device Fund and the Medical Device Commercialisation Training Program. The medical devices sector is an area of research excellence in NSW and it is great to see the development of programs that support the commercialisation of impactful technologies.”
The QB3 Rosenman Scholarship will see Dr Gho and Dr Weaver spend two years in San Francisco, where they will work together with clinicians to advance their technology and develop new medical products.
Applications for the Medical Device Fund will open next week.
For more information on the Medical Device Commercialisation Program (MDCTP) or the Medical Devices Fund:
go to www.health.nsw.gov.au/ohmr or www.atp-innovations.com.au
About ATP Innovations
ATP Innovations is Australia’s leading technology business incubator. ATP Innovations accelerates the growth of technology companies that target global markets, by providing advice and guidance from seasoned entrepreneurs, access to investors, customers and domain specialists, and world-class infrastructure tailored to the needs of startup companies.
The ATP Innovations Accelerator HUB is home to Startmate, Ignition Labs and university accelerator programs. ATP Innovations’portfolio comprises over 65 companies from the software, hardware and life science sectors.
ATP Innovations is the 2014 NBIA Incubator of the Year. Awarded by the National Business Incubation Association (NBIA), the peak global body for business incubation and entrepreneurship with over 2200 members in more than 60 countries.